-
27-08-2014, 11:29 AM
#9101
Originally Posted by winner69
Maybe PEB only sent it through at 10am
For my ongoing education, must a Company only make an announcement PRIOR to the opening bell?
-
27-08-2014, 11:36 AM
#9102
If PEB had posted it at 3.30 in the afternoon would it be expected that NZX cancel all trades for the day, or the day before as well perhaps.
We have had many instances of announcements after opening by PEB, midmorning and afternoon
BLT is different in the announcement in the paper on Sunday preceded the sharemarket and it should have been available to the market prior to opening. It was not therefore there is a problem
Not in the same boat, IMHO
-
27-08-2014, 11:46 AM
#9103
Is this positive or negative
Nice of Kaiser to help PEB do a bigger and more statistical significant trial.
Obviously Kaiser are not so skeptical of the benefits of CxBladder that they are rejecting it outright.
Wonder whether PEB have to pay Kaisers administration fees for this !
So is this N thousand unpaid tests?
And presumably no paid tests via Kaiser until 2015 if then ?
Still a very speculative stock and thus:
Increased SP = Increased risk.
Best Wishes
Paper Tger
-
27-08-2014, 12:13 PM
#9104
Hmmmm. Interesting! Kaiser Permanente seed funded the development of Predictive Biosciences CertnDx.
Cheers
Miner
-
27-08-2014, 12:26 PM
#9105
Originally Posted by Dentie
For my ongoing education, must a Company only make an announcement PRIOR to the opening bell?
Absolutely not. I would say the issue is that NZX takes 20 mins to put an announcement up, so if you want something announced prior to open, then get off your ass and get in by 9.30.
-
27-08-2014, 12:44 PM
#9106
Member
This is massive News! Yes, no sales. But the opportunity to prove your product can improve the current testing situation, reduce liability to urologists, save life's, and set a standard other insurers have to match!
I have no idea how this news should affect the short term share price.
This is a toe in the door, if you don't value this information. I would question your business knowledge and experience.
-
27-08-2014, 01:05 PM
#9107
Member
Originally Posted by blobbles
I don't get it, all they announced is they are going to run a user program in the USA.
The results will come out "early 2015", this will be reputable proof of how well cxbladder can detect bladder cancer! A USA leading company doing an impartial trial! They're recruiting 2000 people by the looks of it, PEB only used 485 in their trials. Assuming this comes back with similar results, I think it will be fantastic! Very good news.
Originally Posted by MAC
When stocks are much undervalued it only takes a tickle to step them back to where they ought to be.
Absolutely! Look how RAK has jumped over the last month.
This could be really good!?
-
27-08-2014, 01:06 PM
#9108
Originally Posted by Carpenterjoe
This is massive News! Yes, no sales. But the opportunity to prove your product can improve the current testing situation, reduce liability to urologists, save life's, and set a standard other insurers have to match!
I have no idea how this news should affect the short term share price.
This is a toe in the door, if you don't value this information. I would question your business knowledge and experience.
Yep, it all adds further clarity to the forward revenue schedule too;
>>> Network providers go first, Pacific Edge have told us it takes effectively seven months from sign up to commercial sales commencing. Of the four signed up thus far, the first (FedMed) was signed up in October last year, the latest (Multiplan) in May this year.
>>> Medicare sales have been occurring for over a year now and Pacific Edge have told us that those revenues are being held by Medicare awaiting release upon contract signing, maybe before the end of this reporting period on 30th September, maybe after.
>>> And now we see the start of HMO sign up's with what seems like around about a nine month lead from user programme commencement to effective commercial clinical sales accumulating.
A few overlapping timelines can start to add up.
Kicking some numbers around, that prospective Kaiser Permanente contract could alone be worth US$10 to US$20M per annum in revenues.
-
27-08-2014, 01:13 PM
#9109
Member
I just had a thought... I am pretty sure that in the last year that I recall seeing some news from PEB about how they have further increased the accuracy of their test, as that is one thing that they want to do -- seems entirely prudent.
Is it therefore likely that we should see an even better result from this Kaiser user program than the initial one?
-
27-08-2014, 01:34 PM
#9110
Originally Posted by Xerof
Absolutely not. I would say the issue is that NZX takes 20 mins to put an announcement up, so if you want something announced prior to open, then get off your ass and get in by 9.30.
Thank you sir!
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks